JP2004521951A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004521951A5 JP2004521951A5 JP2003511833A JP2003511833A JP2004521951A5 JP 2004521951 A5 JP2004521951 A5 JP 2004521951A5 JP 2003511833 A JP2003511833 A JP 2003511833A JP 2003511833 A JP2003511833 A JP 2003511833A JP 2004521951 A5 JP2004521951 A5 JP 2004521951A5
- Authority
- JP
- Japan
- Prior art keywords
- sulfamate
- dosage unit
- unit according
- dose
- estrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940011871 estrogen Drugs 0.000 claims 9
- 239000000262 estrogen Substances 0.000 claims 9
- IIACRCGMVDHOTQ-UHFFFAOYSA-M sulfamate Chemical compound NS([O-])(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-M 0.000 claims 8
- OEFRKKWTZSUQCT-LPNAZMDGSA-N C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(NS(=O)(=O)O)O)CCC4=C3C=CC(=C4)O Chemical class C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(NS(=O)(=O)O)O)CCC4=C3C=CC(=C4)O OEFRKKWTZSUQCT-LPNAZMDGSA-N 0.000 claims 5
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 claims 4
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 claims 4
- 229960004845 drospirenone Drugs 0.000 claims 4
- 230000007423 decrease Effects 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 230000003442 weekly effect Effects 0.000 claims 2
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 206010010904 Convulsion Diseases 0.000 claims 1
- 206010013496 Disturbance in attention Diseases 0.000 claims 1
- 206010016825 Flushing Diseases 0.000 claims 1
- 206010022998 Irritability Diseases 0.000 claims 1
- 206010027951 Mood swings Diseases 0.000 claims 1
- VGHIBOFCBWMZNZ-ZXXIGWHRSA-N NS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 Chemical compound NS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 VGHIBOFCBWMZNZ-ZXXIGWHRSA-N 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 206010037180 Psychiatric symptoms Diseases 0.000 claims 1
- YXYXCSOJKUAPJI-ZBRFXRBCSA-N [(8r,9s,13s,14s,17s)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] sulfamate Chemical compound NS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 YXYXCSOJKUAPJI-ZBRFXRBCSA-N 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 230000002485 urinary effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30476001P | 2001-07-13 | 2001-07-13 | |
| DKPA200101109 | 2001-07-13 | ||
| PCT/IB2002/003354 WO2003006027A1 (en) | 2001-07-13 | 2002-07-12 | Combination of drospirenone and an estrogen sulphamate for hrt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004521951A JP2004521951A (ja) | 2004-07-22 |
| JP2004521951A5 true JP2004521951A5 (https=) | 2006-01-05 |
Family
ID=26069054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003511833A Pending JP2004521951A (ja) | 2001-07-13 | 2002-07-12 | Ｈｒｔのためのドロスピレノン及びエストロゲンスルファメートの組み合わせ |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US6869941B2 (https=) |
| EP (1) | EP1406634A1 (https=) |
| JP (1) | JP2004521951A (https=) |
| WO (1) | WO2003006027A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6787531B1 (en) * | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
| US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
| EP1535618A1 (en) * | 2003-11-26 | 2005-06-01 | Schering Aktiengesellschaft | Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions |
| US8475838B2 (en) * | 2005-06-03 | 2013-07-02 | Sandoz Ag | Rapidly-dissolving pharmaceutical composition for inhibiting ovulation |
| US20070254036A1 (en) * | 2006-04-13 | 2007-11-01 | Besins Healthcare Sa | Treatment of menopause associated symptoms |
| WO2008031631A2 (en) * | 2006-09-16 | 2008-03-20 | Bayer Schering Pharma Aktiengesellschaft | Oral modified release formulations |
| EP1902711A1 (en) * | 2006-09-20 | 2008-03-26 | KAIROSmed GmbH | Oral modified release formulations containing Drospirenon and 8-Prenylnaringenin for use in Hormone Replacement Therapy (HRT) |
| CN100396693C (zh) * | 2006-11-08 | 2008-06-25 | 浙江大学 | 1,4-孕二烯-16β-甲基-17α,21-二羟基物的制备方法 |
| US20100204146A1 (en) * | 2007-09-17 | 2010-08-12 | Preglem S.A. | Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women |
| TW200927141A (en) * | 2007-11-22 | 2009-07-01 | Bayer Schering Pharma Oy | Vaginal delivery system |
| JP2012502988A (ja) * | 2008-09-16 | 2012-02-02 | プレイテックス プロダクツ エルエルシー | 月経抑制、避妊、およびホルモン補充療法のための製剤、ならびにその投与方法 |
| ES2533584T3 (es) * | 2010-04-15 | 2015-04-13 | Bayer Intellectual Property Gmbh | Formas de dosificación oral sólidas de dosis baja para TSH |
| US20130137664A1 (en) | 2010-04-15 | 2013-05-30 | Bayer Intellectual Property Gmbh | Low-dosed solid oral dosage forms for hrt |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3942641A (en) * | 1972-05-05 | 1976-03-09 | Syntex Corporation | Dispensing packages containing novel cyclic progestogen-interrupted estrogen oral contraceptive regimens |
| DE2652761C2 (de) * | 1976-11-16 | 1985-11-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
| GB9118478D0 (en) * | 1991-08-29 | 1991-10-16 | Imperial College | Steroid sulphatase inhibitors |
| NL9301562A (nl) * | 1993-09-09 | 1995-04-03 | Saturnus Ag | Preparaat voor substitutietherapie. |
| DE4344462C2 (de) * | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
| DE4447714C2 (de) * | 1994-08-09 | 1998-02-05 | Jenapharm Gmbh | Verwendung von Estra-1,3,5(10)-trien-Derivaten zur Hormonsubstitutions-Therapie |
| DE19633685C1 (de) | 1996-08-12 | 1997-10-09 | Schering Ag | Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens |
| DE19651000A1 (de) | 1996-12-01 | 1998-06-04 | Schering Ag | Oxyiminopregnancarbolactone |
| DE19654609A1 (de) | 1996-12-20 | 1998-06-25 | Schering Ag | Therapeutische Gestagene zur Behandlung von Premenstrual Dysphoric Disorder |
| DE19834931A1 (de) * | 1998-07-28 | 2000-02-24 | Jenapharm Gmbh | Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie |
| AU6795000A (en) | 1999-08-18 | 2001-03-13 | Curagen Corporation | Defense-related signaling genes and methods of use |
| US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
| ATE442147T1 (de) | 2000-01-18 | 2009-09-15 | Bayer Schering Pharma Ag | Pharmazeutische zubereitung enthaltend drospirenon |
-
2002
- 2002-07-12 JP JP2003511833A patent/JP2004521951A/ja active Pending
- 2002-07-12 EP EP02755534A patent/EP1406634A1/en not_active Withdrawn
- 2002-07-12 WO PCT/IB2002/003354 patent/WO2003006027A1/en not_active Ceased
- 2002-07-15 US US10/194,970 patent/US6869941B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004521951A5 (https=) | ||
| JP2002522391A (ja) | 前立腺配合物 | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| EP2248519A3 (en) | Non-mucoadhesive film dosage forms | |
| WO2000002573A1 (en) | Natural composition and method for the treatment of sexual dysfunction | |
| JP2005516913A5 (https=) | ||
| AR045289A1 (es) | Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento | |
| ME02584B (me) | Farmaceutske kompozicije za terapiju zamene glukokortikoida | |
| JP2008542299A5 (https=) | ||
| JP4996803B2 (ja) | 抗高血圧剤に対する抵抗性及び関連状態を処置する方法及び処方物 | |
| JP2002540148A5 (https=) | ||
| AR049197A1 (es) | Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona | |
| WO2017101889A1 (zh) | 一种疏肝中草药组合物的配方、制备方法及应用 | |
| CN106511161A (zh) | 一种对口腔溃疡有治疗功效的中草药牙膏 | |
| CN101721624A (zh) | 一种治疗更年期综合症的中药组合物及其制备方法 | |
| CN102772414A (zh) | 治疗潮红的s-米氮平 | |
| AU2019396829B2 (en) | Adhesive pad | |
| SG145717A1 (en) | Composition for releasing a weak base for an extended period of time | |
| TW200904452A (en) | New drospirenone/17β-estradiol regimen, pharmaceutical combination, product and kit for performing this regimen | |
| US20180289708A1 (en) | Low dose oral dipyridamole compositions and uses thereof | |
| JP2008247874A (ja) | 育毛促進剤 | |
| CN111184762A (zh) | 鸡尾酒疗法的固体制剂 | |
| RU2002129298A (ru) | Применение галантамина для лечения психоневрологического поведения, связанного с болезнью альцгеймера | |
| HUP0101514A2 (hu) | Készítmény és eljárás gyulladásos bélbetegség kezelésére N-acetilglükózamin vastagbélbe történő adagolásával | |
| CN1415359A (zh) | 一种滋补强身、延缓衰老的保健食品 |